Department of Obstetrics and Gynecology, University Medical Center Gronigen, University of Gronigen, Groningen, The Netherlands (J.B., M.J.M.)
Department of Pathology, Duke University Medical Center, Durham, North Carolina (K.C.S.)
Jackson Laboratory for Genomic Medicine, Farmington, Connecticut (G.N.)
Department of Pathology, Brigham and Women’s Hospital (C.B.S., D.L.K., M.R.N., C.P.C.)
Department of Pathology, Beth Israel Deaconess Hospital (J.H.), Boston, Massachusetts
Institute of Molecular Medicine, University of Texas Health Sciences Center, Houston, Texas (W.X.)
J.B. and K.C.S. contributed equally.Supported by grants from the Department of Defense (Pilot award OC130500; to C.P.C. and Ovarian Cancer Academy Grant OC160444 to W.X. and C.P.C.).
The authors declare no conflict of interest.
Address correspondence and reprint requests to Christopher P. Crum, MD, Department of Pathology, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115. E-mail: [email protected].